Cardiac sarcoidosis: from diagnosis to treatment
Open Access
- 23 November 2021
- journal article
- research article
- Published by Palacky University Olomouc in Biomedical Papers
- Vol. 165 (4), 347-359
- https://doi.org/10.5507/bp.2021.057
Abstract
Sarcoidosis is a systemic granulomatous disease of unknown cause. Its clinical presentations are heterogeneous and virtually any organ system can be affected, most commonly lungs. The manifestations of cardiac sarcoidosis (CS) are heterogenous depending on the extent and location of the disease and range from asymptomatic forms to life-threatening arrhythmias as well as to progressive heart failure. Cardiac involvement is associated with a worse prog-nosis. The diagnosis of CS is often challenging and requires a multimodality approach based on current international recommendations. Pharmacological treatment of CS is based on administration of anti-inflammatory therapy (mainly corticosteroids), which is often combined with heart failure medication and/or antiarrhythmics. Nonpharmacological therapeutic approaches in CS cover pacemaker or defibrillator implantation, catheter ablations and heart transplanta-tion. This review aims to summarize the current understanding of CS including its epidemiology, etiopathogenesis, clinical presentations, diagnostic approaches, and therapeutic possibilities.Keywords
This publication has 53 references indexed in Scilit:
- Corticosteroid Therapy for Cardiac Sarcoidosis: A Systematic ReviewCanadian Journal of Cardiology, 2013
- Heart Transplantation for End-Stage Heart Failure Due to Cardiac SarcoidosisTransplantation Proceedings, 2013
- Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged AdultsCirculation: Arrhythmia and Electrophysiology, 2011
- Cardiac sarcoidosis: a comprehensive reviewVideosurgery and Other Miniinvasive Techniques, 2011
- Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysisEuropean Respiratory Journal, 2007
- Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosisTissue Antigens, 2007
- Evaluation of the Accuracy of Gadolinium-Enhanced Cardiovascular Magnetic Resonance in the Diagnosis of Cardiac SarcoidosisJournal of Invasive Cardiology, 2005
- Mycobacterial catalase–peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosisThe Journal of Experimental Medicine, 2005
- Molecular genetic studies of HLA class II alleles in sarcoidosisTissue Antigens, 1994
- Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.Journal of the American College of Cardiology, 1978